Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin

by Weerawat Manosuthi, Somnuek Sungkanuparph, Ammarin Thakkinstian, Asda Vibhagool, Sasisopin Kiertiburanakul, Sasivimol Rattanasiri, Wisit Prasithsirikul, Jongkol Sankote, Apicha Mahanontharit, Kiat Ruxrungtham
Published 2018

Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis

by Reshma S. Autar, Ferdinand W.N.M. Wit, Jongkol Sankote, Apicha Mahanontharit, Thanomsak Anekthananon, Piroon Mootsikapun, Khanjtta Sujaikaew, David A. Cooper, Joep M.A. Lange, Praphan Phanuphak, Kiat Ruxrungtham, David M. Burger
Published 2018